RESULTS: Physical, Social and Economic impact was perceived by 59.3%, 47.7 and 51.2% of patients, respectively. About 31.8 % suffered from both social and economic impact, while 76.9% patients suffered from any one form of impact. Physical impacts suffered were poor sleep (44.2%), limitation of daily activity (38.4%), and sporting/exercise (39.5%). Physical impact was more perceived by patients not using of inhaled corticosteroid (ICS) as compared to those using ICS (45.7% vs. 25.5%; P = 0.008). Patients with comorbidity, in low occupational class and not on National Health Insurance Scheme perceived more economic impact.